Jim Simons
BCDA icon

Jim Simons’s BioCardia BCDA Stock Holding History

Jim Simons’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,900
Closed -$16.8K – 3205
2026
Q1 		$16.8K Buy
+13,900
New +$17.4K ﹤0.01% 3180
2024
Q1 		– Sell
-5,887
Closed -$59K – 3707
2023
Q4 		$59K Buy
5,887
+5,187
+741% +$42.1K ﹤0.01% 3425
2023
Q3 		$5K Sell
700
-480
-41% -$8.08K ﹤0.01% 3600
2023
Q2 		$47K Buy
1,180
+140
+13% +$4.31K ﹤0.01% 3626
2023
Q1 		$30K Buy
1,040
+100
+11% +$3.32K ﹤0.01% 3757
2022
Q4 		$29K Sell
940
-13
-1% -$370 ﹤0.01% 3894
2022
Q3 		$28K Sell
953
-34
-3% -$879 ﹤0.01% 3854
2022
Q2 		$21K Buy
987
+74
+8% +$1.77K ﹤0.01% 4110
2022
Q1 		$28K Buy
+913
New +$27.1K ﹤0.01% 3977
2021
Q4 		– Sell
-2,903
Closed -$137K – 3893
2021
Q3 		$137K Sell
2,903
-3,912
-57% -$192K ﹤0.01% 3276
2021
Q2 		$406K Sell
6,815
-13,532
-67% -$822K ﹤0.01% 3040
2021
Q1 		$1.32M Buy
+20,347
New +$1.27M ﹤0.01% 2475

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Jim Simons's BCDA Position: Q2 2026 in Review

Jim Simons sold out of BioCardia (BCDA) in Q2 2026, closing a stake of 13,900 shares — an estimated $16.8K sold.

Jim Simons first reported a position in BCDA in Q1 2021 and held it in 12 quarters. The position peaked at $1.32M in Q1 2021. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • Jim Simons reported no remaining BioCardia position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 13,900 BioCardia shares in Q2 2026, an estimated $16.8K.
  • Jim Simons first reported a position in BioCardia in Q1 2021 and held it in 12 quarters.
  • Jim Simons's BioCardia position peaked at $1.32M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.